Advertisement
For patients with epilepsy

Valproic Acid Concentration Drops With Ketogenic Diet

0
Changes in serum concentrations of other anti-epileptic drugs not found to be significant
Antibiotic prescriptions are filled by nearly 60 percent of patients newly diagnosed with acute conjunctivitis

Nearly 60 Percent With Conjunctivitis Fill Antibiotic Rx

0
Blacks and Latinos less likely to fill prescriptions; higher-income, educated patients more likely to fill rx
Isotretinoin may impair wound healing after tattooing

Isotretinoin May Impair Wound Healing After Tattoo

0
Case report describes 19-year-old woman who had unsatisfactory aesthetic result from tattooing
From 1991 to 2014 there was minimal change in health spending by state

1991-2014 Saw Minimal Change in Health Spending Per State

0
Recession and recovery, implementation of health reform impacted health care coverage
Patients with low back pain who are depressed are more likely to be prescribed opioids

Opioid Rx Too Often Given to Back Pain Patients With Depression

0
Researchers find these patients are also more likely to get higher doses of opioids
Most serious adverse events in nursing homes are caused by medication errors

Causes of Serious Adverse Events in Nursing Homes Identified

0
Most serious adverse events caused by medication errors, falls, delayed or inappropriate intervention
For Caucasian patients with chronic hepatitis B

HCC Drops Beyond Five Years of Entecavir/Tenofovir Tx for Hep B

0
Older age, lower platelets at baseline and year five, liver stiffness ≥12 kPa linked to HCC development
For development of oncology drugs in Japan

Strategies Compared for Cancer Medication Submission Lags

0
Shorter submission lag for global trial, early-initiation bridging strategy vs late-initiation strategy
For patients with acute heart failure

Early Loop Diuretic Tx Tied to Lower Mortality in Heart Failure

0
Early-treatment group had significantly lower in-hospital mortality even after adjustment
For patients with previously untreated stage IV or recurrent non-small-cell lung cancer

Nivolumab Doesn’t Up PFS in Stage IV or Recurrent NSCLC

0
Findings in patients with previously untreated disease with PD-L1 expression level of ≥5 percent